Incidental findings
Incidental Lung Nodule Found on — Your PET-CT
A small spot in the lung, found while the scan was looking for something else, is one of the most frequent unexpected findings on PET-CT. The pathway from here depends on what the nodule looks like — not simply on the fact that it appeared.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026
- Very common — Incidental lung nodules appear on a significant proportion of PET-CT scans done for cancer staging or monitoring.
- Most causes are benign — In India, old TB infection and healed granulomas are the most frequent explanations — not malignancy.
- Two things matter most — Size and whether the nodule is active on the PET component together guide the next investigation.
- Your team decides — The right follow-up cannot be read from the report alone — your clinical history is part of the decision.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
An incidental lung nodule is a small spot in the lung that a PET-CT picked up while scanning for a different reason. In a large proportion of cases these are caused by old infections or scarring rather than cancer. Size and whether the nodule is active on PET guide what your team investigates next.
PET-CT at CION starts from Rs 10,499 — among the lowest published prices in Hyderabad, with no hidden charges. Indicative price, as of September 2026.
What does it mean when a lung nodule is found on a PET-CT?
A nodule is a small rounded area of tissue in the lung. When it is described as incidental, it means the scan found it while looking for something else — not part of what your team was originally investigating.
In India, old tuberculosis, healed fungal infections, and scar tissue from past pneumonia are among the most common causes. These leave marks in the lung that can appear on any scan, including PET-CT.
The finding itself does not tell your team whether the nodule is harmful. That depends on size, PET activity, and how it compares to any earlier scans you have had.
How does PET activity change what happens next?
| Feature | PET-inactive nodule | PET-active (FDG-avid) nodule |
|---|---|---|
| What it shows | No significant uptake of the glucose tracer | Increased tracer uptake compared to surrounding tissue |
| Common causes in India | Old TB scar, healed infection, benign growth | Active infection, inflammation, or — in a proportion — malignancy |
| Does it mean cancer? | Not automatically — most PET-inactive nodules are non-malignant in general population studies | Not necessarily — infection and inflammation also cause PET activity |
| Urgency | Generally lower; interval CT is the typical next step | Needs prompt oncology review |
| Typical next step | Repeat CT scan after an interval your team sets | Further imaging, biopsy, or multidisciplinary team discussion |
PET-CT Partner Centres
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
Does the size of the nodule change what investigation you need?
Yes. Smaller nodules are generally managed with periodic CT surveillance rather than biopsy. Larger, PET-active nodules are more likely to need active investigation.
The Fleischner Society and NCCN publish size-based guidance that oncologists apply when deciding follow-up intervals. The same measurement can mean different things depending on your cancer history and the nodule's density.
Ask your oncologist what the size in your report means for your situation — not what a general threshold online would suggest.
What do the words in your scan report mean?
- Nodule
- A small rounded area of lung tissue, generally described as smaller than 3 cm. Larger areas are called masses and are investigated differently.
- Incidental finding
- Something the scan found that was not the original reason for scanning. It requires its own assessment alongside your planned investigation.
- FDG-avid
- The nodule absorbed more glucose tracer than the tissue around it. This can reflect cancer, active infection, or inflammation — PET alone cannot distinguish between them.
- Ground-glass opacity
- A hazy area in the lung that does not fully hide the structures beneath it. These behave differently from solid nodules and usually need longer surveillance.
- Calcified nodule
- A nodule containing calcium deposits, commonly left behind by old TB infection. Calcification is generally a lower-risk feature, though individual assessment still applies.
- Fleischner Society guidelines
- Internationally referenced criteria advising when and how often to follow up lung nodules on CT, based on size and risk factors. Your oncologist applies these alongside your cancer history.
Questions people ask when they see this on their report
Does this mean I now have lung cancer on top of my existing cancer?
Not necessarily — and it should not be the first assumption. The majority of incidental nodules on PET-CT are caused by benign processes, and in India calcified granulomas from old infection are very common. What your team is assessing is whether this specific nodule needs further investigation. That answer comes from size, PET activity, and your clinical history.
Could this be a spread of my known cancer to the lung?
It is one possibility your team will consider, and ruling it in or out is exactly why the nodule is followed up. A PET-CT finding alone is not enough to diagnose metastasis. Your oncologist will weigh whether the nodule is FDG-avid, whether it is growing, and whether it fits the spread pattern expected from your primary cancer before advising on next steps.
My nodule is very small — why is follow-up needed at all?
Small nodules are generally lower-risk, and follow-up is often a repeat CT after several months rather than an immediate biopsy. The purpose is to confirm the nodule has not grown — stability over time is itself clinically meaningful information. Your team will tell you what interval they are setting and what change would prompt a sooner review.
Can old tuberculosis cause a nodule to appear on PET-CT?
Yes. TB leaves calcified granulomas and scar tissue that appear on CT and can show mild FDG uptake, particularly if residual activity is present. This is one reason incidental lung nodules are common in India, where TB exposure is widespread. Your team will interpret the finding in the context of your specific clinical history.
Will I need a biopsy?
Not necessarily. Whether a biopsy is recommended depends on the nodule's size, PET activity, location, and your overall clinical situation. Many nodules are managed with imaging surveillance only. When a biopsy is advised, it is usually because knowing the tissue type would change what treatment you receive. Your team will explain what threshold they are using.
A whole-body PET-CT at CION is Rs 10,499 — among the lowest published prices in Hyderabad — with a free Rs 950 oncologist consultation to talk through your report. Indicative price, as of September 2026.
Explore 94 more Understanding Your PET-CT Report topics
Incidental Findings
- A Second Unrelated Cancer Found on PET-CT
- An Incidental Bone Finding on PET-CT
- An Incidental Breast Finding on PET-CT
- An Incidental Kidney or Adrenal Finding
- An Incidental Liver Lesion on PET-CT
- An Incidental Lung Nodule Found on PET-CT
- An Incidental Prostate Finding on PET-CT
- An Incidental Thyroid Nodule on Your PET Scan
- Do All Incidental Findings Need Investigation?
- Focal Bowel Uptake: Could It Be a Polyp?
- Incidental Findings on a PET-CT Scan: What They Are
- Incidental Heart Findings on a Cancer PET Scan
- The Cost of Chasing an Incidental Finding
- What to Ask Your Doctor About an Incidental Finding
False Positives, False Negatives & Pitfalls
- Bladder, Kidney and Ureter Activity on PET
- Bone Marrow Uptake After Growth Factor Injections
- Bowel Uptake: Normal, Inflammation or Something Else?
- Brown Fat Uptake: A Common Cause of Confusing Findings
- Does a Suspicious PET Finding Always Need a Biopsy?
- Getting a Second Read of Your PET-CT Images
- How Often Is a PET-CT Scan Wrong?
- Muscle Uptake After Exercise or Injections
- Thymic and Rebound Uptake in Younger Patients
- Uptake After Radiotherapy: Inflammation or Disease?
- Uptake at a Biopsy or Surgery Site
- What Causes a False Negative on a PET Scan?
- What Causes a False Positive on a PET Scan?
- What Happens If Two Scans Disagree?
- Which Cancers Do Not Show Well on PET-CT?
- Why the Brain Always Lights Up on PET
Infection, TB & Inflammation on PET
- Can Tuberculosis Look Like Cancer on a PET Scan?
- Dental Infection and Jaw Uptake on PET
- Fungal Infection and Abscess on PET-CT
- How Long Should You Wait After an Infection Before a PET Scan?
- If It Might Be Infection, What Test Comes Next?
- Inflammation After Injections, Vaccines and Cannulas
- Old Healed TB and Calcified Nodes on PET-CT
- PET-CT for Fever of Unknown Origin
- PET-CT for Suspected Infection in Implants and Prostheses
- PET-CT for Vasculitis and Inflammatory Conditions
- Pneumonia and Recent Chest Infection on PET
- Sarcoidosis on PET-CT: The Great Mimic
- TB or Cancer? How Doctors Tell Them Apart
- Thyroid Uptake on PET: Diffuse vs Focal
Reading Your Report: Core Terms
- 'Cannot Be Excluded' and Other Cautious Phrases
- 'Deauville Score' on a Lymphoma PET Report
- 'FDG Avid': What It Means on Your Report
- 'Hypermetabolic': What the Word Actually Means
- 'Hypometabolic' and 'Photopenic' Findings
- 'Impression' vs 'Findings': Which Section Should You Read?
- 'Interval Change' and 'Stable Since Previous Study'
- 'Krenning Score' on a DOTANOC or DOTATATE Report
- 'Lymphadenopathy' on Your PET Report
- 'Metabolically Active Disease': What It Tells You
- 'Metastasis' and 'Distant Spread' on Your Report
- 'Mildly FDG Avid' vs 'Intensely FDG Avid'
- 'No Abnormal FDG Uptake': Is That a Clear Scan?
- 'Physiological Uptake': Normal Areas That Always Light Up
- 'Residual Disease' vs 'Complete Metabolic Response'
- 'Sub-Centimetre Node' and Why Size Matters on PET
- 'Suspicious for Malignancy': How Certain Is That?
- How Long Does a PET-CT Report Take?
- How to Read Your PET-CT Report: A Section-by-Section Guide
- Should You Read Your Own PET-CT Report Before the Consult?
- TNM Staging on a PET-CT Report
- Why Your Report Mentions the Liver and Blood Pool
Response Assessment Scores & Criteria
- Complete Metabolic Response: What It Means
- Deauville Score 1 to 5: The Lymphoma Scale Explained
- End-of-Treatment PET Scan: What It Decides
- How Doctors Judge Whether Treatment Is Working on PET-CT
- Interim PET Scan During Chemotherapy: Why It Is Done
- Metabolic Response vs Size Response: Why They Differ
- PERCIST Criteria: How Metabolic Response Is Measured
- Partial Metabolic Response: Is That Good Enough?
- Progressive Metabolic Disease: What Happens Next
- RECIST vs PERCIST: Size vs Activity
- Stable Metabolic Disease: Good News or Bad?
- Tumour Flare and Pseudoprogression on PET
- What Is a Deauville 3 and Why Is It Ambiguous?
- Why the Scan Says One Thing and You Feel Another
SUV Values Explained
- Comparing SUV Between Two Scans: Is It Meaningful?
- Does a Higher SUV Mean a More Aggressive Cancer?
- Factors That Change Your SUV Reading
- High SUV but Not Cancer: When the Number Misleads
- Is My SUVmax of 4 High? Reading Your Specific Number
- Low SUV but Still Cancer: The PET-Negative Cancers
- SUV in Non-Cancer Conditions
- SUVmax, SUVmean and SUVpeak: What Is the Difference?
- What Is SUV on a PET Scan?
- What Is a Normal SUV Value?
- What SUV Value Indicates Cancer?
- Why Blood Sugar Changes Your SUV Result
- Why Did My SUV Go Down but Not to Zero?
- Why Did My SUV Go Up After Treatment?
Your next step
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Common questions
Frequently asked questions
How common is it to find a lung nodule on a PET-CT?
Very common. Studies reviewed by the Fleischner Society show a significant proportion of chest CT scans in general populations detect at least one lung nodule. In India the rate is thought to be higher because of widespread TB and granulomatous infection. Finding a nodule does not in itself change the management of the condition the scan was originally ordered for.
Does a PET-active nodule always mean cancer?
No. FDG uptake reflects metabolic activity, which increases in cancer but also in active infections and inflammatory conditions. A PET-active nodule tells your team that a closer look is needed — it is not a diagnosis. Your oncologist will interpret the level of activity alongside the nodule's size, shape, and your clinical history before deciding on next steps.
My report gives the nodule size in millimetres — does that tell me how serious it is?
Size is one input, not a verdict. Guidance from the Fleischner Society and NCCN groups nodules into broad size categories with different follow-up recommendations for each — and those are applied more cautiously for patients with a cancer history. Ask your oncologist what the measurement in your report means for your specific situation rather than searching for a threshold online.
Will the nodule go away on its own?
It depends on the cause. A nodule from an active infection may shrink with treatment. A calcified TB scar will remain stable on future scans but does not need intervention. A malignant nodule will not resolve without treatment. Follow-up imaging is designed to answer this — whether the nodule grows, shrinks, or stays stable shapes the next clinical decision.
Should I mention the nodule to my oncologist, or will they already know?
Bring it up at your next appointment. Scan reports go to your oncologist, but it is worth confirming they have seen the incidental finding and that a follow-up plan is in place. Ask two things: their assessment of the nodule, and whether a follow-up scan or referral has been arranged. A documented plan means nothing falls through in a busy department.
Does an incidental nodule change my current cancer treatment?
In most cases treatment continues while the nodule is assessed in parallel. If the nodule represents metastasis, that could change your disease staging and potentially the treatment approach. Until the assessment is complete, avoid drawing conclusions about what it means for your treatment. Ask your oncologist to address the nodule and your ongoing treatment as two separate questions.